A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Clinical trial NCT01184885 · COMPLETED

Trial details

NCT number: NCT01184885
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lymphoid Malignancies (New or Relapsed)Acute Lymphoblastic Leukemia Burkitt Lymphoma Lymphoblastic Lymphoma Mantle Cell Lymphoma Adult T-cell Leukemia/Lymphoma

Start date: 2010-07-01
Primary completion: 2011-03-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.